Advertisements

Доксициклин

Quick links to important sections

Доксициклин

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Advertisements

Overview of Доксициклин

Quick Facts

Property Description
Active ingredient Doxycycline (Doxycyclinum)
Form Capsules, tablets, oral suspension, injection
Pharmacological class Tetracycline antibiotics, Bacteriostatic agent
Common use Combating bacterial infections and certain inflammations
Origin Semisynthetic

What Type of Antibiotic is Doxycycline?

Doxycycline is a semisynthetic, broad-spectrum antibiotic that belongs to the second-generation tetracycline class of antimicrobials. Chemically, it is derived from the naturally occurring oxytetracycline and is functionally classified as a bacteriostatic agent, meaning its principal mechanism is to inhibit the growth and replication of susceptible bacteria, rather than directly killing them. This classification means the medicine works by suppressing the bacteria, allowing the body's immune system to clear the infection.

Compared to first-generation tetracyclines, Doxycycline is clinically recognized for its high lipophilicity (fat-solubility), a characteristic that significantly improves its absorption and allows it to achieve effective therapeutic concentrations in various bodily tissues, including those difficult for other antibiotics to penetrate.

What is Doxycycline Made Of and What Forms Does it Come In?

The active ingredient is Doxycycline, an International Nonproprietary Name (INN) which is available globally under numerous trade names. It is manufactured as either the more water-soluble doxycycline hyclate salt or the more stable doxycycline monohydrate salt, depending on the desired pharmaceutical preparation. As a product containing a single active compound, Doxycycline is formulated for both oral and intravenous (IV) route of administration, including oral capsules and tablets (some in delayed-release forms), liquid suspension, and powder for injection.

What is the General Purpose of Doxycycline?

The primary purpose of Doxycycline is to suppress infections caused by a wide spectrum of susceptible microorganisms due to its broad-spectrum capability. Importantly, Doxycycline also demonstrates unique anti-inflammatory and immunomodulatory effects that extend beyond its direct antimicrobial action. These properties mean that the medication provides a secondary benefit by helping to reduce swelling and inflammation associated with various diseases. This dual function—microbial suppression and inflammation control—provides a versatile therapeutic advantage for treating conditions like severe acne, where both bacterial action and tissue inflammation must be addressed.

Advertisements

What side effects are possible with Доксициклин?

Possible side effects and safety information

The medicine's safety profile is documented by regulatory authorities (such as the FDA and EMA) based on classified frequencies and specific systemic effects. Adverse reactions are grouped by system-organ class and formally categorized as Common, Uncommon, Rare, or Frequency Not Known.

Adverse Reaction Categories

Classification Examples of Officially Listed Reactions
Common Nausea, vomiting, headache, photosensitivity reaction
Rare Benign intracranial hypertension, haemolytic anaemia, anaphylactic reaction
Systemic Gastrointestinal disorders, Nervous system disorders, Skin and subcutaneous tissue disorders

Commonly listed effects predominantly involve the gastrointestinal system and skin. Gastrointestinal reactions like nausea and vomiting are often reported, particularly at the start of treatment. Skin reactions include photosensitivity, where heightened sensitivity to sun exposure is officially documented.

Serious Adverse Reactions are explicitly noted in regulatory documents. These include Benign Intracranial Hypertension (a condition involving increased pressure around the brain), potentially life-threatening Severe Cutaneous Adverse Reactions (e.g., Stevens-Johnson Syndrome), and Pseudomembranous Colitis (due to Clostridium difficile overgrowth), which can occur during or after therapy.

Population-Specific Safety Considerations are defined for vulnerable groups. The official labeling states that use during the second and third trimesters of pregnancy and in children under 8 years carries the risk of permanent tooth discoloration and inhibition of bone growth. Furthermore, caution is mandated for use in patients with pre-existing hepatic impairment.

Advertisements

Overdose and Emergency Response

Overdose and When to Seek Help

The official regulatory documentation for Doxycycline (Doxycyclinum) outlines specific manifestations and mandatory actions in the event of an acute overdose. Overdose is primarily characterized by the exacerbation of known adverse effects, particularly severe gastrointestinal disturbances such as vomiting, nausea, and diarrhea. A critical concern documented in regulatory labeling is the potential for hepatotoxicity, or damage to the liver, which requires clinical monitoring.


Required Emergency Actions

Official government guidance mandates that any suspected or confirmed overdose requires the patient to seek immediate medical attention or contact emergency services.

Management Category Regulatory Statement
Antidote Availability No specific antidote is known for Doxycycline overdose.
Treatment Protocol Treatment is to be strictly symptomatic and supportive.
Supportive Measures Procedures may include gastric lavage or the administration of activated charcoal to reduce systemic absorption.
Required Monitoring Intensive medical monitoring is required, with a focus on evaluating liver and renal function to manage potential systemic toxicity.

The regulatory profile emphasizes that due to the risk of severe systemic outcomes and the lack of an antidote, immediate external medical intervention is essential for all overdose scenarios.

Advertisements

Therapeutic Uses of Доксициклин

What Доксициклин treats: Main Uses and Benefits

The medication is applied in clinical settings where symptoms are primarily related to susceptible bacteria and accompanying inflammation. Its therapeutic use is recognized for various antimicrobial applications.

It is relevant in situations that involve acute or unstable symptom patterns associated with systemic and respiratory infections, and for vector-borne illnesses like Lyme disease and Rocky Mountain spotted fever. Doxycycline is also commonly used across conditions characterized by long-term, fluctuating symptom patterns, notably acne and rosacea, and is applied in contexts where additional symptomatic support is needed. Furthermore, its prophylactic use supports patients in avoiding the development of symptoms related to malaria in travelers, and it is used for post-exposure support against certain sexually transmitted infections.

“This supportive use helps patients cope more steadily with symptom fluctuations by easing pronounced, visible manifestations and reducing the risk of developing debilitating symptoms.”


Quick Fact: Supportive Role in Symptom Management

Property Description
Primary Focus Easing systemic discomfort and reducing inflammation
Symptom Type Fever, malaise, papules, pustules, redness
Patient Benefit Supports functional stability and day-to-day comfort

Regulatory References

  1. NIH MedlinePlus overview
Advertisements

Eligibility and Restrictions for Use

Who Can and Cannot Use Doxycycline (Доксициклин)

The eligibility for Doxycycline use is defined by regulatory authorities based on population safety and development status.

Contraindications (Must Not Use)

Population Group Restriction Basis
Hypersensitivity Known allergy to doxycycline or any other tetracycline antibiotic.
Pregnancy Contraindicated, particularly during the second and third trimesters.
Lactation Contraindicated; excreted into breast milk.
Concurrent Oral Retinoids Contraindicated due to risk of Intracranial Hypertension.

Age and Condition Restrictions

The medicine is generally permitted for Adults and Children 8 years of age. However, use is Not Recommended for children < 8 years of age for routine treatment due to the risk of permanent tooth discoloration. An exception exists for life-threatening conditions (e.g., Rocky Mountain spotted fever) where potential benefits outweigh the risk, and alternative therapies are unavailable. Additionally, use requires Caution for patients with hepatic impairment and those with existing conditions such as Systemic Lupus Erythematosus, as the condition may be exacerbated.

Advertisements

What should I know about interactions with other medicines?

Interactions with other medicines and products

Doxycycline may interact with several medicinal products and substances, necessitating dosage adjustments or timing separation to avoid reduced efficacy or increased toxicity risk. These interactions are categorized based on regulatory documents.

Contraindicated Combinations

Co-administration with Isotretinoin or other oral retinoids is contraindicated due to the documented risk of developing benign intracranial hypertension (pseudotumor cerebri), a severe toxicological interaction. Use with the anesthetic Methoxyflurane is also prohibited due to the risk of fatal renal toxicity.

Pharmacokinetic Interactions

Substances that are strong enzyme inducers, such as Phenytoin, Carbamazepine, and Barbiturates, can increase the metabolic clearance of doxycycline, leading to a decreased half-life and potentially reduced therapeutic effect. Conversely, Doxycycline can affect the metabolism of other drugs.

Absorption and Timing Requirements

Absorption of Doxycycline is significantly reduced by chelation with divalent or trivalent cations. This includes medications like antacids (containing aluminum, calcium, or magnesium), iron preparations, and Bismuth Subsalicylate. To ensure adequate systemic exposure, these substances must be administered at least 2 to 3 hours apart from the Doxycycline dose.

Pharmacodynamic Interactions

  • Oral Anticoagulants (e.g., Warfarin): Doxycycline may enhance the anticoagulant effect by depressing plasma prothrombin activity, often requiring a downward adjustment of the anticoagulant dose.
  • Oral Contraceptives: Concomitant use may lead to reduced effectiveness of hormonal contraceptives, requiring the use of supplementary contraceptive measures.
Advertisements

Mechanism of Action

Blocking Bacterial Protein Synthesis

The primary action of Doxycycline is achieved through reversible non-covalent binding to the bacterial 30S ribosomal subunit. This molecular interaction blocks the necessary access of aminoacyl-tRNA to the ribosomal A site . By interfering with this critical step, the drug halts the elongation of peptide chains and prevents the synthesis of essential bacterial proteins. This inhibition leads to a bacteriostatic effect that contributes to the control of microbial population size.

Inhibition of Host Enzyme Activity

Independently of its antibacterial role, Doxycycline acts as a non-competitive inhibitor of specific host enzymes, particularly Matrix Metalloproteinases (MMPs) such as MMP-8 and MMP-9. These MMPs are responsible for the pathological breakdown of the Extracellular Matrix (ECM) during heightened inflammatory responses. By suppressing MMP activity and reducing the release of proinflammatory cytokines (e.g., TNF-alpha), the drug limits the pathological breakdown of connective tissue and influences inflammatory signaling, which reduces tissue-destructive physiological processes.

Advertisements

Dosage and Administration Information

How to Use Doxycycline: Administration and Usage

The following describes the standard clinical procedures for the administration of Doxycycline.

Administration Scope

Doxycycline is administered via two primary routes:

  • Oral (PO): Available as capsules, tablets, or liquid suspension.
  • Intravenous (IV) Infusion: Prepared from powder for injection.

Labeled Dosing and Frequency

The standard adult regimen begins with a loading dose of 100 mg every 12 hours on the first day, followed by a maintenance dose of 100 mg once daily or 50 mg twice daily. For severe infections, the dose is typically 100 mg every 12 hours throughout the course. Pediatric dosing for children over 8 years of age and under 45 kg is weight-based, starting with 4.4 mg/kg on day one, divided into two doses.

Procedural Requirements

Administration Method Required Procedure
Oral Dose Must be taken with a full glass of liquid while the patient remains in an upright position (sitting or standing) to reduce the risk of esophageal irritation. Taking with food or milk is permitted if stomach upset occurs.
IV Infusion The powder must be reconstituted and then further diluted into an appropriate IV solution (e.g., 0.9% Sodium Chloride) to a final concentration between 0.1 mg/mL and 1.0 mg/mL. It must be administered as a slow infusion over 1 to 4 hours.

Special Rules

Use in children under 8 years of age is generally not recommended due to the potential for permanent tooth discoloration, but it is indicated for specific severe or life-threatening conditions (e.g., anthrax). If a dose is missed, take it as soon as possible unless it is near the time for the next scheduled dose; do not double the dose to compensate.

The duration of therapy varies significantly, ranging from a single dose for some conditions to several months for certain prophylaxis or chronic regimens.

Advertisements

Recent Clinical Evidence

Research evidence / Overview of studies for Доксициклин

Evidence for Use in Systemic and Respiratory Infections

Research has explored its role in addressing various bacterial infections, particularly those affecting the respiratory system, such as Community-Acquired Pneumonia (CAP). Studies conducted include short-term Randomized Controlled Trials (RCTs) and systematic reviews, which research examined clinical outcomes in comparison to other agents. The research examined primary outcomes related to functional measures, such as time until a patient's condition stabilized and clinical cure rates. Evidence remains limited regarding its use in more severe or complicated respiratory infections. Long-term outcomes and potential functional changes months after the acute episode are not fully established. Research efforts are ongoing to refine understanding of its place in the overall evidence landscape for these conditions.

Evidence for Use in Sexually Transmitted Infections and Prophylaxis

Doxycycline was studied for the management of bacterial Sexually Transmitted Infections (STIs), including Chlamydia and Syphilis. More recently, research has explored its use as a preventative measure, specifically post-exposure (PEP) and pre-exposure (PrEP) prophylaxis. Prophylaxis trials primarily focused on high-risk adult populations, particularly men who have sex with men and transgender women. Trials reported on the incidence rates of specific bacterial STIs in study populations that used the prophylactic agent. Data for its use as STI chemoprophylaxis in certain populations, such as cisgender heterosexual women, remain insufficient.

Evidence for Use in Chronic Inflammatory Skin Conditions (Acne and Rosacea)

Doxycycline was evaluated in double-blind, controlled trials for its application in conditions associated with inflammatory or irritative states, such as severe acne and papulopustular rosacea. Studies focused on outcomes linked to inflammatory states by monitoring changes in inflammatory lesion counts and official disease severity scores. Findings describe patterns observed in these clinical outcome measurements compared to placebo in the research setting. Long-term effects are not fully established regarding the sustained outcome after the medicine is discontinued, particularly for chronic management.

Evidence in Special Populations

Research has primarily focused on healthy adults. Data for certain groups remain insufficient or explicitly excluded from core studies. Various infection studies included children over the age of 8. However, trial data for children under 8 years of age is limited. Research does not determine the effect on pregnancy-related populations, and comparative evidence is lacking for these groups.

Advertisements

Frequently Asked Questions (FAQ)

Common questions about Доксициклин (FAQ)


Q: Can I take Doxycycline with milk or food?

A: Official administration guidelines state that taking the medicine with food or milk is generally permitted if a patient experiences stomach upset or nausea. This approach is generally permitted to help manage potential digestive irritation. However, product labeling may advise avoiding dairy or mineral-containing products (cations) to ensure optimal systemic absorption.


Q: What should I do if I miss a dose of Doxycycline?

A: Official information advises that a missed dose may be taken as soon as it is remembered. However, if it is already close to the time for the next scheduled dose, official guidance suggests skipping the missed dose and returning to the regular schedule. Regulatory sources explicitly state that the dose must not be doubled to compensate for the one that was missed.


Q: Why do I need to stay upright after taking the pill?

A: Regulatory documents detail that taking the medicine while sitting or standing is a required procedure, and it should be done with a full glass of liquid. This requirement is in place to help mitigate the risk of the tablet or capsule causing irritation or ulceration of the esophagus (food pipe).


Q: How long does a course of Doxycycline last?

A: The length of Doxycycline therapy is highly variable, depending on the specific condition being treated. Official prescribing information indicates that the duration ranges from a single dose for certain uses to several months for some preventative or chronic regimens. The precise duration is determined by the prescribing health professional based on the specific condition.


Q: How quickly does Doxycycline start working for a skin infection like acne?

A: Official clinical pharmacology information indicates that Doxycycline is rapidly absorbed into the bloodstream, reaching its peak concentration in the blood within approximately two hours after dosing. While the medicine's absorption is rapid, the specific timeframe for the clinical onset of action and observable improvement of symptoms is generally not detailed in the product label.


Q: Is it okay to drink alcohol while I'm taking Doxycycline?

A: Product information notes that chronic or heavy consumption of alcohol may affect how Doxycycline is processed by the body. Official information indicates that this interaction may increase the rate at which the medicine is eliminated, which could potentially reduce its overall therapeutic effectiveness.


Q: What happens if I stop taking Doxycycline early?

A: Patient counseling information from regulatory sources stresses the importance of completing the full course of therapy exactly as prescribed. Discontinuation of the antibiotic before the course is finished may decrease treatment effectiveness and can increase the potential for the development of drug-resistant bacteria.


Q: What is the shelf life for the oral suspension after it's been mixed?

A: The official product labeling for the oral suspension specifies stability requirements after the powder has been mixed with liquid (reconstituted). Any portion of the mixed suspension that is unused must be discarded after 14 days. This timeline is established to help maintain the medicine's expected potency and stability profile.

Advertisements

How should Доксициклин be stored and disposed of?

Storage Conditions for Doxycycline

All forms of doxycycline must be stored at controlled room temperature, specifically between 20 C and 25 C (68 F and 77 F), with regulatory documents specifying storage must not exceed 25 C. The medicine requires mandatory protection from light and moisture and must be kept in a tightly closed, light-resistant container.

For the oral suspension form, any unused product must be discarded after two weeks (14 days) to maintain stability. The medicine must always be stored out of the sight and reach of children.


Disposal Instructions

Unused, expired, or unwanted doxycycline must be disposed of according to official regulatory guidance. This includes following FDA guidelines and complying with all local requirements for the safe disposal of pharmaceutical waste.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Доксициклин found in:

A-Z Index: